HEALTH

Boosting HPV Vaccine Rates: What's Holding Back Young Women with HIV?

Greater Masaka, UgandaTue Mar 11 2025
In Central Uganda, a recent study dug into why young women with HIV aren't getting the HPV vaccine. The focus was on 100 girls and young women aged 10 to 24. These young women were part of a trial in four healthcare facilities that provide antiretroviral therapy. The study happened between January and March 2024. The study looked at many things. It looked at things like age, religion, and education. It also looked at how the young women felt about the HPV vaccine. It looked at what might stop them from getting it. It looked at how likely they thought they were to get HPV. It looked at what they knew about HPV and cervical cancer. It also looked at how many of them had actually gotten the vaccine. The results showed that only 31 out of 100 young women had gotten the vaccine. This is a pretty low number. The study found two big reasons why some young women were more likely to get the vaccine. The first was whether they had had sex before. Those who hadn't were four times more likely to get vaccinated. The second was how much they knew about HPV. The more they knew, the more likely they were to get the vaccine. What is surprising is that things like how likely they thought they were to get HPV, what they knew about cervical cancer, and what might stop them from getting the vaccine didn't seem to matter much. This shows that there's a lot of work to do to get more young women with HIV to get the HPV vaccine. We need to figure out what's stopping them and make sure they know the facts about HPV. This is especially important for young women with HIV. It is important to remember that this study only looked at a small group of young women in one part of Uganda. So, the results might not apply to everyone. The study used a health belief model to figure out what might predict whether someone would get the vaccine. This model looks at things like how likely someone thinks they are to get a disease, how serious they think the disease is, and what might stop them from doing something about it. The study also did a logistic regression analysis. This is a fancy way of saying they looked at a bunch of different factors and tried to figure out which ones were most important in predicting whether someone would get the vaccine. It is important to note that the study only looked at a small group of young women in one part of Uganda. So, the results might not apply to everyone.

questions

    How can the health belief model be adapted to better address the specific barriers and predictors of HPV vaccine uptake in this demographic?
    How can healthcare providers better educate adolescent girls and young women living with HIV about the importance of the HPV vaccine?
    Is the low uptake rate of the HPV vaccine among adolescent girls and young women living with HIV a result of a deliberate campaign to downplay its importance?

actions